• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Thursday, July 10, 2025
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home Tech

Mark Cuban launches online pharmacy

by Jigyasa Prashar
January 23, 2022
in Tech
Reading Time: 2 mins read
0
Mark Cuban says no to Bitcoin ETF

Image Source: Fintechs.fi

TwitterWhatsappLinkedin

Mark Cuban, the billionaire investor, launched an online pharmacy on Thursday that sells more than 100 generic pharmaceuticals at a low cost, with the purpose of being “radically transparent” in its price talks with pharmaceutical companies. According to a release, the Mark Cuban Cost Plus Drugs Company (MCCPDC) is a certified pharmaceutical wholesaler that buys drugs directly from manufacturers, bypassing middlemen to cut the cost of more than 100 medications.

You might also like

Poland to Report Grok to EU Over Chatbot’s “Offensive Comments” on Politicians

Turkey Bans xAI’s Grok Over Offensive Content, Including Insults to President Erdoğan

Starlink Clears Final Regulatory Hurdle, Poised for Launch in India

Courtesy: cnbc.com

For example, the leukaemia medicine imatinib is available on MCCPDC for $47 per month, compared to $9,657 at retail. According to the statement, the online pharmacy’s generic rates include a 15% margin on top of genuine manufacturer prices and a $3 pharmacist charge.

Mark Cuban is an American billionaire entrepreneur, television personality, and media mogul who, according to Forbes, has a net worth of $4.3 billion and is placed #177 on the Forbes 400 list for 2020. He is the co-owner of 2929 Entertainment and the owner of the Dallas Mavericks, a professional basketball franchise in the National Basketball Association (NBA). On the ABC reality television show Shark Tank, he is also one of the key “shark” investors.

The MCCPDC claims that generic markups average “at least” 100 percent, while the Wall Street Journal claims that in some cases it exceeds 1,000 percent. Customers must pay for their meds out of pocket because the company does not process insurance claims, despite the fact that its drugs are less expensive than most insurance plans’ deductibles and copays.

To order drugs through the MCCPDC website, customers must first obtain a fresh prescription from their doctor. In a cold email, MCCPDC CEO Alex Oshmyansky pitched Cuban a proposal for a low-cost generic pharma company. It was first released in January of last year. They were influenced by “Pharma Bro” Martin Shrkeli’s price raise of the life-saving medicine Daraprim from $13.50 to $750 per tablet while he was CEO of Turing Pharmaceuticals. Last year, Cuban told Forbes that the cost of generic medications was “crazy.” He claimed he chose to name the company after himself to “show capitalism can be kind” and to “convey the message I am all in.” It is unclear how much money he put into the company.

The pharmacy’s development was announced by Cuban in October 2021, according to The Wall Street Journal. The Dallas Morning News reported that it debuted in 2018 under a different moniker.

By the end of the year, the company hopes to have completed the construction of a $11 million pharmaceutical facility in Dallas, which would span around 22,000 square feet.

 

Tags: #COVID#markcuban#patient#pharmacy#sharktankNewsOnlinetechtrending
Tweet54SendShare15
Previous Post

Crypto mining and gold-backed stablecoins may be permitted in Russia

Next Post

Tesla Model X Plaid real world test shows it can go 0-60mph in 2.3 seconds

Jigyasa Prashar

Recommended For You

Poland to Report Grok to EU Over Chatbot’s “Offensive Comments” on Politicians

by Sneha Singh
July 10, 2025
0
Poland to Report Grok to EU Over Chatbot's "Offensive Comments" on Politicians

Poland has taken a direct move against hate speech generated by AI after announcing plans to officially report Elon Musk's AI chatbot, Grok, to the European Union. The...

Read more

Turkey Bans xAI’s Grok Over Offensive Content, Including Insults to President Erdoğan

by Sneha Singh
July 10, 2025
0
Turkey Bans xAI's Grok Over Offensive Content, Including Insults to President Erdoğan

Turkey is the first nation in the world to have banned an AI chatbot, blocking access to xAI's Grok after it generated insulting material about President Recep Tayyip...

Read more

Starlink Clears Final Regulatory Hurdle, Poised for Launch in India

by Anochie Esther
July 10, 2025
0
Starlink

After years of anticipation and navigating a complex regulatory landscape, Elon Musk's satellite internet venture, Starlink, has finally received the definitive green light to launch commercial operations in...

Read more
Next Post
Tesla Model X Plaid proves quicker than claimed in real-world 0-60 mph test

Tesla Model X Plaid real world test shows it can go 0-60mph in 2.3 seconds

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook flipkart funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?